J Zhou1, L Fang2, W Y Wu2, F He2, X L Zhang2, X Zhou1, Z J Xiong1. 1. Department of Chemotherapy, Sichuan Cancer Hospital, and. 2. Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, P.R.C.
Abstract
BACKGROUND:Gastrointestinal (gi) symptoms are the most notable side effects of chemotherapeutic drugs; such symptoms are currently treated with drugs. In the present study, we investigated the effect of acupuncture on gi symptoms induced by chemotherapy in patients with advanced gastric cancer. METHODS: A cohort of 56 patients was randomly divided into an experimental group and a control group. All patients received combination chemotherapy with oxaliplatin-paclitaxel. Patients in the experimental group received 30 minutes of acupuncture therapy daily for 2 weeks. The frequency and duration of nausea, vomiting, abdominal pain, and diarrhea, the average days and costs of hospitalization, and quality-of-life scores were compared between the groups. RESULTS:Nausea was sustained for 32 ± 5 minutes and 11 ± 3 minutes daily in the control and experimental groups respectively (p < 0.05). On average, vomiting occurred 2 ± 1 times daily in the experimental group and 4 ± 1 times daily in the control group (p < 0.05). Abdominal pain persisted for 7 ± 2 minutes and 16 ± 5 minutes daily in the experimental and control groups respectively (p < 0.05). On average, diarrhea occurred 1 ± 1 times daily in the experimental group and 3 ± 1 times daily in the control group (p < 0.05). The average quality-of-life score was higher in the experimental group than in the control group (p < 0.05). No adverse events were observed for the patients receiving acupuncture. CONCLUSIONS:Acupuncture, a safe technique, could significantly reduce gi symptoms induced by chemotherapy and enhance quality of life in patients with advanced gastric cancer.
RCT Entities:
BACKGROUND: Gastrointestinal (gi) symptoms are the most notable side effects of chemotherapeutic drugs; such symptoms are currently treated with drugs. In the present study, we investigated the effect of acupuncture on gi symptoms induced by chemotherapy in patients with advanced gastric cancer. METHODS: A cohort of 56 patients was randomly divided into an experimental group and a control group. All patients received combination chemotherapy with oxaliplatin-paclitaxel. Patients in the experimental group received 30 minutes of acupuncture therapy daily for 2 weeks. The frequency and duration of nausea, vomiting, abdominal pain, and diarrhea, the average days and costs of hospitalization, and quality-of-life scores were compared between the groups. RESULTS:Nausea was sustained for 32 ± 5 minutes and 11 ± 3 minutes daily in the control and experimental groups respectively (p < 0.05). On average, vomiting occurred 2 ± 1 times daily in the experimental group and 4 ± 1 times daily in the control group (p < 0.05). Abdominal pain persisted for 7 ± 2 minutes and 16 ± 5 minutes daily in the experimental and control groups respectively (p < 0.05). On average, diarrhea occurred 1 ± 1 times daily in the experimental group and 3 ± 1 times daily in the control group (p < 0.05). The average quality-of-life score was higher in the experimental group than in the control group (p < 0.05). No adverse events were observed for the patients receiving acupuncture. CONCLUSIONS: Acupuncture, a safe technique, could significantly reduce gi symptoms induced by chemotherapy and enhance quality of life in patients with advanced gastric cancer.
Entities:
Keywords:
Acupuncture; chemotherapy; gastric cancer; gastrointestinal symptoms; quality of life
Authors: C A Schiffer; K C Anderson; C L Bennett; S Bernstein; L S Elting; M Goldsmith; M Goldstein; H Hume; J J McCullough; R E McIntyre; B L Powell; J M Rainey; S D Rowley; P Rebulla; M B Troner; A H Wagnon Journal: J Clin Oncol Date: 2001-03-01 Impact factor: 44.544
Authors: Heather Greenlee; Katherine D Crew; Jillian Capodice; Danielle Awad; Donna Buono; Zaixing Shi; Anne Jeffres; Sharon Wyse; Wendy Whitman; Meghna S Trivedi; Kevin Kalinsky; Dawn L Hershman Journal: Breast Cancer Res Treat Date: 2016-03-25 Impact factor: 4.872
Authors: Elena J Ladas; Diane Rooney; Katherine Taromina; Deborah H Ndao; Kara M Kelly Journal: Support Care Cancer Date: 2010-06-18 Impact factor: 3.603
Authors: Paul A Cybularz; Karen Brothers; Gurneet M Singh; Jennifer L Feingold; Mark E Lewis; Michelle L Niesley Journal: Med Acupunct Date: 2015-06-01
Authors: Oliver Grundmann; Saunjoo L Yoon; Joseph J Williams; Lucio Gordan; Thomas J George Journal: Integr Cancer Ther Date: 2019 Jan-Dec Impact factor: 3.279
Authors: Xiaomei Miao; Hongying Wu; Yan Liu; Shu Zhang; Chaohui Li; Jie Hao Journal: Evid Based Complement Alternat Med Date: 2022-07-30 Impact factor: 2.650